What is BlueSemi?
BlueSemi is dedicated to revolutionizing healthcare through the creation of non-invasive health tech products. The company's core focus lies in analyzing six key vital signs, offering a comprehensive approach to personal health monitoring. By leveraging advanced technology, BlueSemi aims to make health insights more accessible and actionable for individuals, positioning itself as a key player in the burgeoning digital health sector. The company's commitment to innovation is evident in its pursuit of solutions that simplify health management.
How much funding has BlueSemi raised?
BlueSemi has raised a total of $69.3M across 2 funding rounds:
Angel/Seed
$300K
Debt
$69M
Angel/Seed (2020): $300K with participation from Microsoft, KLA, Samsung Electronics, and Google
Debt (2021): $69M led by Global Emerging Markets
Key Investors in BlueSemi
Microsoft
Microsoft Corp. is a global technology giant known for its software, hardware, and cloud services. Its investment in BlueSemi suggests a strategic interest in the health tech sector and potential synergies with its existing technology platforms.
KLA
KLA Corporation specializes in semiconductor manufacturing equipment, focusing on process control and metrology. Their involvement may indicate an interest in the underlying technology or manufacturing processes related to BlueSemi's devices.
Global Emerging Markets
Global Emerging Markets (GEM) is an alternative investment group focused on emerging markets. Their participation in BlueSemi's funding round highlights the company's potential for significant growth and market impact within its operational regions.
What's next for BlueSemi?
With the recent influx of capital, BlueSemi is poised for an accelerated growth trajectory. The major strategic investment signals strong confidence from backers in the company's vision and technological capabilities. This funding will likely be instrumental in scaling operations, expanding research and development efforts, and potentially entering new markets. BlueSemi's focus on non-invasive vital sign analysis places it at the forefront of preventative and personalized healthcare, a sector experiencing significant investment and consumer interest.
See full BlueSemi company page
